Bio-Techne Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Bio-Techne Corp.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
/ 
Frequently asked questions
To buy Bio-Techne Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Bio-Techne Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Bio-Techne Corp. is TECH:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Bio-Techne Corp. has its primary listing on NASDAQ. You can trade Bio-Techne Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Bio-Techne Corp. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Bio-Techne Corp. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Bio-Techne Corp..